. Doxorubicin induces Oct-6 DNA binding in different cancer cell lines. EMSA was performed using the hH2B-Oct probe in the presence of nuclear extracts (10 μg) from H460 cells (positive control for each panel) or from the indicated cell line, unstimulated (−) or treated with Dox (0.5 μM) for 24 h. DNA binding complexes with electrophoretic mobility corresponding to Oct-1 or Oct-6 are indicated in the figures. Figure S8 . Oct-6 regulates p21 expression: direct binding to p21 promoter. EMSA was performed using two different consensus Octamer sequences from p21 promoter [1.1 Kb (left panel) (A) and -1.8 kb (right panel) (B)] as probe, in the presence of nuclear extracts (10 μg) from unstimulated (−) or Dox treated H460 cells for 24 h. Where indicated, 100 ng of specific consensus Oct or non-specific cold competitor was added to the reaction mixture to confirm specificity. Where indicated, anti-Oct-1 or anti-Oct-6 antibody was added to the reaction mixture. DNA binding complexes containing Oct-1 or Oct-6 are indicated in the figures. EMSA shown in the figure are representative of 3 independent experiments, all displaying similar results.
